• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Host&Microbe: Cellular Inhibitor of Apoptosis Protein cIAP2 Protects against Pulmonary Tissue Necrosis during Influenza Virus Infection to Promot

tetano

Editor, Senior Moderator
Cellular Inhibitor of Apoptosis Protein cIAP2 Protects against Pulmonary Tissue Necrosis during Influenza Virus Infection to Promote Host Survival

Ian Ga?l Rodrigue-Gervais1, 6, Katherine Labb?2, 6, Maryse Dagenais3, Jeremy Dupaul-Chicoine3, Claudia Champagne1, Alexandre Morizot1, Alexander Skeldon3, Erik L. Brincks5, Silvia M. Vidal4, Thomas S. Griffith5 and Maya Saleh1, 2, 3, Go To Corresponding Author,

1 Department of Medicine, McGill University, Montr?al, QC H3A 1B1, Canada
2 Department of Microbiology and Immunology, McGill University, Montr?al, QC H3A 1B1, Canada
3 Department of Biochemistry, McGill University, Montr?al, QC H3A 1B1, Canada
4 Department of Human Genetics, McGill University, Montr?al, QC H3A 1B1, Canada
5 Department of Urology, Center for Immunology, University of Minnesota, Minneapolis, MN 55455, USA
Corresponding author

6 These authors contributed equally to this work



Graphical Abstract

Highlights

cIAP2−/− mice show enhanced susceptibility to influenza infection despite virus control
cIAP2−/− epithelial cell necrosis during infection underlies impaired airway integrity
RIPK1 inhibition or RIPK3 deletion improves survival of influenza infected cIAP2−/− mice
Hematopoietic deficiency of Fas ligand or TRAIL reversed susceptibility of cIAP2−/− mice

Summary
Cellular inhibitors of apoptosis proteins (cIAPs) are essential regulators of cell death and immunity. The corresponding contributions of IAPs to infectious disease outcomes are relatively unexplored. We find that mice deficient in cIAP2 exhibit increased susceptibility and mortality to influenza A virus infection. The lethality was not due to impaired antiviral immune functions, but rather because of death-receptor-induced programmed necrosis of airway epithelial cells that led to severe bronchiole epithelial degeneration, despite control of viral replication. Pharmacological inhibition of RIPK1 or genetic deletion of Ripk3, both kinases involved in programmed necrosis, rescued cIAP2-deficient mice from influenza-induced lethality. Genetic deletion of the death receptor agonists Fas ligand or TRAIL from the hematopoietic compartment also reversed the susceptibility of cIAP2-deficient mice. Thus, cIAP2-dependent antagonism of RIPK3-mediated programmed necrosis critically protects the host from influenza infection through maintenance of pulmonary tissue homeostasis rather than through pathogen control by the immune system.


http://www.cell.com/cell-host-microbe/retrieve/pii/S1931312813004368?script=true
 
Back
Top